Abstract:In pursuit of unsymmetrical precursors for the novel series of anthracenyl-isoxazole amide (AIM) antitumor agents, a series of substituted anthracenes were subjected to bromination and re-aromatization in our study, during which we solved four single crystal X-ray diffractometry (Sc-xrd) structures which we report herein. The C-9 nitrile oxide, after its reaction with bromine, was isolated, but when subjected to re-aromatization, it returned to the starting 10-bromo nitrile oxide 1, which did provide an accurate crystal structure, with R = 0.018. The 10-halogenated 3-(9'-anthryl)-isoxazole esters were subjected to bromination and re-aromatization. Surprisingly, the yields obtained in the presence of the isoxazole were reasonably good (62–68% isolated yields), and the major diastereomers allowed for the characterization using Sc-xrd. The penta bromo product 2 showed a trans, trans, cis relationship for the four bromines on the A-ring of the anthracene, and we observed that for the unit cell, the atropisomers displayed a 1:1 ratio at the chiral axis between the isoxazole and anthrancene rings. Similarly, the 10-chloro 3 indicated a ratio of 1:1 at the chiral axis in the crystal structure. A base-induced re-aromatization afforded 3,10-dihalogenated analogues selectively in very good yields (X = Cl, 89%; X = Br 92%), of which the dibromo 4 was characterized using Sc-xrd. The improved yields of the unique diastereomeric bromination products suggested the consideration of a novel electrophilic aromatic substitution mechanism driven by the stereo-electronic environment, imposed by the isoxazole ester substituent. The promise of the application of this chemistry in the future development of AIM antitumor agents is suggested.

Synthesis of (+)-9-Amino-4-demethoxy-9-deoxydaunomycinone

Improved Synthetic Process for 3-Benzyloxy-4-n-butylaniline Hydrochloride

Synthesis of 3-Aminopyrrolidine and its N-alkylating Derivatives

Bioconversion of Deoxysugar Moieties to the Biosynthetic Intermediates of Daunorubicin in an Engineered Strain of Streptomyces Coeruleobidus

Synthesis of the C1–C12 Acid Fragment of Amphidinolide T Marine Macrolides Via SmI2-mediated Enantioselective Reductive Coupling of Aldehydes with a Chiral Crotonate

A Facile Synthesis of Spin Labeled 4′-Epi-N-Trifuoroactyldaunomycin Derivatives

Synthesis and Cytotoxicity of 9‐substituted Benzo[de]chromene‐7,8‐dione and 5‐benzyl‐9‐substituted Benzo[de]chromene‐7,8‐dione

Synthesis and in Vitro Antitumor Activity of Substituted Anthracene‐1,4‐diones.

Synthesis of 2,4-Diaminoquinazoline and 2,4-Diaminopyrido-[2,3-d]pyrimidine Derivatives

Synthesis of Key Intermediate of Diazepinomicin

A Convenient and Efficient Synthesis of 2-Acetyl-5,8-dimethoxy-1,4-naphthoquinone

A New Synthetic Method of Nintedani

First total synthesis and determination of the absolute configuration of 1-N-methyl-3-methylamino-[N-butanoicacid-3-(9-methyl-8-propen-7-one)-amide] -benzo[f][1,7]naphthyridine-2-one, a novel benzonaphthyridine alkaloid

Synthesis of 1-Allyl-6-chloro-7-methyl-1,4-dihydroquinoxaline-2,3-dione

A large-scale synthesis of the bioreductive drug 1,4-bis{[2-(dimethylamino)ethyl]amino}-5,8-dihydroxyanthracene-9,10-dione bis-N-oxide (AQ4N)

Synthetic process improvement for natural products mansonone E and F

Diastereoselective synthesis of 3,3-disubstituted 3-nitro-4-chromanone derivatives as potential antitumor agents

Synthetic Studies On (-)-Lemonomycin: An Efficient Asymmetric Synthesis Of Lemonomycinone Amide

Synthesis and Structure of Unsymmetrical Anthracenyl-Isoxazole Antitumor Agents Via the Diastereoselective Bromination of 3-(9′-Anthryl)-Isoxazole Esters

Total Synthesis of (−)-Daphnezomines A and B

Synthesis of Dihydromotuporamine C Via 3‐azonia‐cope Rearrangement of 11‐membered Cyclic Α‐vinylamine